Mallinckrodt to sell Canadian drug manufacturing unit for $250M - St...
09/10/19
Mallinckrodt to sell Canadian drug manufacturing unit for $250M St. Louis Business Journal
Mallinckrodt PLC said Tuesday it would sell Canadian drug manufacturer BioVectra Inc. for $250 million, freeing up more cash as it deals with potential liabilities ...
[more]